Clinical Trial Update: Single Bolus Recombinant Nonimmunogenic Staphylokinase Versus Single Bolus Tenecteplase (Metalyse) in STEMI [Phase 3]

View source ↗

Summary

A Phase 3 trial compares a single bolus recombinant nonimmunogenic staphylokinase with a single bolus tenecteplase (Metalyse) for ST-elevation myocardial infarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• Metalyse (tenecteplase)
• Staphylokinase (recombinant nonimmunogenic) (staphylokinase)

Snippet

Sponsor: Supergene, LLC | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED | Results posted: 2025-03-20